From: Impact of Ivabradine on renal function in septic patient with early renal impairment
Group C (n=25) | Group I (n=25) | Tests | ||
---|---|---|---|---|
t/X2 | P-value | |||
Age (years) | 44.16±10.54 | 45.32±9.78 | 0.404 | 0.688 |
Weight (kg) | 83.60±8.23 | 85.32±9.42 | 0.688 | 0.495 |
Cause of Sepsis | ||||
Pneumonia | 12(48%) | 13(52%) | 0.267 | 0.966 |
Abdominal | 8(32%) | 7(28%) | ||
Necrotizing fasciitis | 2(8%) | 3(12%) | ||
Septic wound | 2(12%) | 2(8%) | ||
Amount of fluid prior to inclusion | 5410.48±490.81 | 5394.00±398.98 | 0.130 | 0.897 |
SOFA score (Median (IQR) | 9 (7 -12.25) | 8(6.75-12) | 0.496 | |
Optimization of adequate resuscitation | ||||
Serum lactate | 1.96±0.46 | 2.15±0.44 | 1.542 | 0.130 |
MAB | 68.20±1.29 | 67.56±1.66 | 1.522 | 0.135 |
CVP | 9.72±1.28 | 10.24±1.16 | 1.505 | 0.139 |
(SvO2) | 69.40±3.32 | 70.16±3.20 | 0.825 | 0.414 |
HERAT RATE | 98.20±7.21 | 96.84±3.33 | 0.856 | 0.396 |
Serum Cystatin C (mg/l) | 1.71±0.16 | 1.79±0.17 | 1.571 | 0.123 |
eGFR C (ml/min/1.73 m2) | 44.28±2.88 | 45.76±3.24 | 1.706 | 0.094 |
DAILY URINE OUTPUT | 844.52±107.76 | 838.00±118.52 | 0.204 | 0.840 |
DAILY NOREPIEPHRINE : 0.3-0.5 μg/Kg/Min | 0.44±0.16 | 0.47±0.20 | 0.539 | 0.592 |